Topology-based kernels with application to inference problems in Alzheimer's disease
Deepti Pachauri1, Chris Hinrichs, Moo K Chung
1Alzheimer’s Disease Neuroimaging Initiative and Department of Computer Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA. pachauri@cs.wisc.edu
IEEE Transactions on Medical Imaging
|May 4, 2011
Summary
Researchers developed new methods to calculate similarity matrices for brain imaging data, improving Alzheimer's disease (AD) research. These techniques enhance statistical inference for neurological disorders using cortical thickness measures.
Area of Science:
- Neuroimaging
- Statistical Learning
- Computational Anatomy
Background:
- Alzheimer's disease (AD) research increasingly uses statistical learning for imaging data analysis.
- Support vector machines (SVM) and kernel methods are common but require predefined kernel matrices.
- Measuring similarity between complex neuroimaging data, like cortical thickness, is challenging for existing methods.
Purpose of the Study:
- To introduce novel techniques for computing similarity matrices from topologically-based attributed neuroimaging data.
- To enable the use of clinically relevant measures like cortical thickness in statistical inference frameworks.
- To address limitations in current kernel-based methods for neuroimaging analysis.
Main Methods:
- Developed new methods to compute similarity matrices for topologically-based attributed data.
- Leveraged topological feature persistence to characterize signals like cortical thickness.
- Constructed kernel matrices based on these topological characterizations.
Main Results:
- Demonstrated good performance on statistical inference tasks using Alzheimer's Disease Neuroimaging Initiative (ADNI) data (n=356).
- Achieved results without feature selection, dimensionality reduction, or parameter tuning.
- Successfully computed similarity matrices for cortical thickness data, proving the method's utility.
Conclusions:
- The novel techniques effectively compute similarity matrices for complex neuroimaging data.
- These methods enhance the application of statistical learning in Alzheimer's disease research.
- The approach offers a robust way to leverage cortical thickness for improved inference.
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...


